Your browser doesn't support javascript.
loading
A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia.
Hsu, Hannah; Chan, Melissa V; Armstrong, Paul C; Crescente, Marilena; Donikian, Dea; Kondo, Mayuko; Brighton, Timothy; Chen, Vivien; Chen, Qiang; Connor, David; Joseph, Joanne; Morel-Kopp, Marie-Christine; Stevenson, William S; Ward, Christopher; Warner, Timothy D; Rabbolini, David J.
Afiliação
  • Hsu H; Prince of Wales Hospital, Sydney, NSW, Australia.
  • Chan MV; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; National Heart, Blood and Lung Institute, Population Sciences Branch, Framingham, MA, USA.
  • Armstrong PC; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Crescente M; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Donikian D; Haematology NSW Health Pathology Randwick, Sydney, NSW, Australia.
  • Kondo M; Haematology NSW Health Pathology Randwick, Sydney, NSW, Australia.
  • Brighton T; Haematology NSW Health Pathology Randwick, Sydney, NSW, Australia; Prince of Wales Hospital, Sydney, NSW, Australia.
  • Chen V; Haematology, Concord Repatriation General Hospital and NSW Health Pathology, Sydney, NSW, Australia; ANZAC Research Institute and University of Sydney, Sydney, NSW, Australia.
  • Chen Q; Northern Blood Research Centre, Kolling Institute, University of Sydney, Sydney, NSW, Australia; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Connor D; St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
  • Joseph J; St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
  • Morel-Kopp MC; Northern Blood Research Centre, Kolling Institute, University of Sydney, Sydney, NSW, Australia; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Stevenson WS; Northern Blood Research Centre, Kolling Institute, University of Sydney, Sydney, NSW, Australia; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Ward C; Northern Blood Research Centre, Kolling Institute, University of Sydney, Sydney, NSW, Australia; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Warner TD; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Rabbolini DJ; Northern Blood Research Centre, Kolling Institute, University of Sydney, Sydney, NSW, Australia; Northern Clinical School and the Rural Clinical School (Northern Rivers), Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Lismore Base Hospital, Lismore, NSW, Australia. Ele
Pathology ; 54(6): 746-754, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35750510
ABSTRACT
Identification of disordered platelet function is important to guide peri-operative bleeding management as well as long term treatment and prognostic strategies in individuals with platelet bleeding disorders. Light transmission aggregometry (LTA), the current gold standard diagnostic test of platelet function is a time consuming technique almost exclusively performed in specialised laboratories and almost universally unavailable in regional centres in Australia, where there is an unmet need for access to specialised platelet function diagnostic services. 96-well plate-based aggregometry (Optimul, UK), has been utilised in research laboratories as a novel platform to investigate platelet function. We evaluated the Optimul assay at two centres in Australia, one regional and one tertiary metropolitan, to assess its feasibility as a screening test applicable to remote regional centres. Concentration-response curves were established from 45 healthy volunteers at the participating regional hospital and from 31 healthy volunteers at the tertiary institution. Optimul successfully detected anti-platelet effects in individuals taking aspirin (n=4), NSAID (n=2), clopidogrel (n=2) and dual therapy with aspirin and clopidogrel (n=1). When tested in parallel to LTA in individuals referred for the evaluation of abnormal bleeding symptoms there was overall a very good level of agreement between Optimul and LTA [Cohen's kappa (k2)=0.84], supporting its role as a useful screening tool in the assessment of platelet function. Optimul assay performance was quick and the methodology simple, requiring no specialised training or resources to be implemented at either the regional or metropolitan laboratory. Widespread implementation, particularly in regional laboratories within Australia where specialised platelet function testing is unavailable, has the potential to drastically improve the inequity of access to such services.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Plaquetários / Agregação Plaquetária Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Pathology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Plaquetários / Agregação Plaquetária Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Pathology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália